Matthew Angel

Insider Reports History

Location
San Diego, CA
Signature
/s/ Matthew Angel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Angel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. CEO and President, Director, 10%+ Owner Common Stock 8,268,495 $23,730,580 $2.87 03 Feb 2026 By Erigen LLC
Tempest Therapeutics, Inc. CEO and President, Director, 10%+ Owner Employee Stock Option (right to buy) 269,621 04 Feb 2026 Direct
Eterna Therapeutics Inc. President and CEO, Director Stock Option (right to buy) 132,003 12 Jan 2023 Direct

Insider Reports Filed by Matthew Angel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TPST Tempest Therapeutics, Inc. 04 Feb 2026 1 $0 4 CEO and President, Director, 10%+ Owner 06 Feb 2026, 16:26
TPST Tempest Therapeutics, Inc. 03 Feb 2026 0 $0 3 CEO and President, Director, 10%+ Owner 06 Feb 2026, 16:24
ERNA Eterna Therapeutics Inc. 12 Jan 2023 1 $0 4 President and CEO, Director 13 Jan 2023, 18:30
ERNA Brooklyn ImmunoTherapeutics, Inc. 01 Aug 2022 1 $0 4 Interim President and CEO, Director 03 Aug 2022, 20:01
ERNA Brooklyn ImmunoTherapeutics, Inc. 26 May 2022 0 $0 3 Interim President and CEO 01 Jun 2022, 17:00